Vijaya Diagnostic reports Q2 FY27 revenue of INR 2,554 Mn and H1 FY27 of INR 4,864 Mn

Vijaya Diagnostic Centre announced its financial results for the second quarter and first half of FY27. The company reported revenue from operations of INR 2,554 Mn for Q2 FY27 and INR 4,864 Mn for H1 FY27. The presentation also highlights key operational and financial metrics, including EBITDA, PAT, YoY growth percentages, and strategic expansion plans, underscoring a period of sustained growth and development.

Q2 and H1 FY27 Financial Performance Snapshot

Vijaya Diagnostic Centre has released its financial performance for the second quarter (Q2) and the first half (H1) of the financial year 2027. For Q2 FY27, the company reported Revenue from Operations amounting to INR 2,554 Mn. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at INR 1,128 Mn, with an EBITDA Margin of 44.1%. Profit After Tax (PAT) was INR 595 Mn, representing a PAT Margin of 23.3%.

The consolidated performance for H1 FY27 shows robust growth, with Revenue from Operations reaching INR 4,864 Mn. EBITDA for the first half was INR 2,113 Mn (EBITDA Margin of 43.4%), and PAT was INR 1,126 Mn (PAT Margin of 23.1%).

Key Metrics and Growth Highlights

Key operational metrics for Q2 FY27 include 1.37 Mn Footfall and 4.98 Mn Tests performed. The company operates 168 Centres and reported 92% B2C Revenue. Year-on-year (YoY) growth percentages for Q2 FY27 were notable across several areas: 26.7% for Revenue Growth, 37.8% for EBITDA Growth, and 37.4% for PAT Growth. Test Volume Growth was 16.5%, and Footfall Growth was 14.5%.

For H1 FY27, Footfall stood at 2.61 Mn and Tests at 9.57 Mn, with B2C Revenue remaining strong at 92%. YoY growth for H1 FY27 included 24.8% Revenue Growth, 36.0% EBITDA Growth, and 37.5% PAT Growth. Test Volume Growth was 16.5%, and Footfall Growth was 13.7%.

Geographical Contribution and Expansion

The geographical revenue contribution for both periods shows Hyderabad leading with 67%, followed by RoAPT at 20%, Pune at 5%, West Bengal at 3%, and Others at 5%. The company also emphasized its expansion strategies, including the launch of state-of-the-art flagship hubs and spokes in various locations like Bengaluru and Hyderabad, and a strategic foray into Assam with the acquisition of Arya Wellness Centre. The management commentary highlighted sustained growth momentum and plans for further network expansion.

Technological Advancements

Vijaya Diagnostic Centre is also leveraging technology to enhance its services, including AI for CT KUB cases reporting, which aids in automated stone detection, intelligent differentiation, and improving radiologist productivity. Additionally, AI-powered Dental Diagnostics are being implemented for precision care.

Source: BSE

Previous Article

Lloyds Metals approves unaudited results and grants employee stock options